Heparin inhibits IFN-γ-induced fractalkine/CX3CL1 expression in human endothelial cells

被引:18
作者
Hatakeyama, M
Imaizumi, T
Tamo, W
Yamashita, K
Yoshida, H
Fukuda, I
Satoh, K
机构
[1] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Sch Med, Dept Surg 1, Hirosaki, Aomori 0368562, Japan
关键词
endothelial cells; heparin; fractalkine; HUVEC; MNC;
D O I
10.1023/B:IFLA.0000014706.49598.78
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Heparin is primarily used as an anticoagulant but has many biological functions as well. It binds with high affinity to a range of cytokines including interferon-gamma (IFN-gamma) and members of chemokine superfamily. IFN-gamma is a proinflammatory cytokine that plays a pivotal role in immune and inflammatory responses; and in endothelial cells, it regulates the expression of fractalkine/CX3CL1 that is a potent agonist for the chemotaxis and adhesion of monocytes and lymphocytes. We have investigated the effect of heparin on the fractalkine expression in human umbilical vein endothelial cells (HUVEC) in culture. HUVEC were treated with similar to100 mug/mL heparin and the expression of the IFN-gamma-induced fractalkine mRNA and protein were measured by reverse transcription-PCR and western blotting. The IFN-gamma-induced expressions of fractalkine mRNA and protein were inhibited by heparin in a concentration-dependent manner. Heparin also inhibited adhesion of mononuclear cells (MNC) to HUVEC monolayers stimulated with IFN-gamma, but it did not inhibit the MNC adhesion to the monolayers stimulated with interleukin-1beta. Electrophoretic analysis demonstrated direct binding of heparin to IFN-gamma and heparin was found to partially block the binding of IFN-gamma to IFN-gamma receptor (IFN-gamma R). Heparin may play a regulatory role in inflammatory and immune responses by modulating the interaction between leukocytes and the vascular endothelium.
引用
收藏
页码:7 / 13
页数:7
相关论文
共 37 条
[11]   Identification and molecular characterization of fractalkine receptor CX(3)CR1, which mediates both leukocyte migration and adhesion [J].
Imai, T ;
Hieshima, K ;
Haskell, C ;
Baba, M ;
Nagira, M ;
Nishimura, M ;
Kakizaki, M ;
Takagi, S ;
Nomiyama, H ;
Schall, TJ ;
Yoshie, O .
CELL, 1997, 91 (04) :521-530
[12]   Interferon-γ stimulates the expression of CX3CL1/fractalkine in cultured human endothelial cells [J].
Imaizumi, T ;
Matsumiya, T ;
Fujimoto, K ;
Okamoto, K ;
Cui, XF ;
Ohtaki, U ;
Yoshida, H ;
Satoh, K .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) :127-139
[13]  
Imaizumi T, 2000, THROMB HAEMOSTASIS, V83, P949
[14]   Expression of tumor necrosis factor-α in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1α [J].
Imaizumi, T ;
Itaya, H ;
Fujita, K ;
Kudoh, D ;
Kudoh, S ;
Mori, K ;
Fujimoto, K ;
Matsumiya, T ;
Yoshida, H ;
Satoh, K .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) :410-415
[15]   PROTEOGLYCANS - STRUCTURES AND INTERACTIONS [J].
KJELLEN, L ;
LINDAHL, U .
ANNUAL REVIEW OF BIOCHEMISTRY, 1991, 60 :443-475
[16]   Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins - Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents [J].
Koenig, A ;
Norgard-Sumnicht, K ;
Linhardt, R ;
Varki, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :877-889
[17]  
Lee YJ, 1996, J IMMUNOL, V157, P1559
[18]   ANTI-HIV TYPE-1 PROPERTIES OF CHEMICALLY-MODIFIED HEPARINS WITH DIMINISHED ANTICOAGULANT ACTIVITY [J].
LOPALCO, L ;
CICCOMASCOLO, F ;
LANZA, P ;
ZOPPETTI, G ;
CARAMAZZA, I ;
LEONI, F ;
BERETTA, A ;
SICCARDI, AG .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (07) :787-793
[19]   Human interleukin 4 is a glycosaminoglycan-binding protein [J].
Lortat-Jacob, H ;
Garrone, P ;
Banchereau, J ;
Grimaud, JA .
CYTOKINE, 1997, 9 (02) :101-105
[20]   BINDING OF INTERFERON-GAMMA TO HEPARAN-SULFATE IS RESTRICTED TO THE HEPARIN-LIKE DOMAINS AND INVOLVES CARBOXYLIC [BUT NOT N-SULFATED] GROUPS [J].
LORTAT-JACOB, H ;
GRIMAUD, JA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1117 (02) :126-130